CN105652022B - 血栓弹力图仪质控品及其制备方法 - Google Patents
血栓弹力图仪质控品及其制备方法 Download PDFInfo
- Publication number
- CN105652022B CN105652022B CN201511026362.9A CN201511026362A CN105652022B CN 105652022 B CN105652022 B CN 105652022B CN 201511026362 A CN201511026362 A CN 201511026362A CN 105652022 B CN105652022 B CN 105652022B
- Authority
- CN
- China
- Prior art keywords
- values
- plasma
- blood
- solution
- quality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000003908 quality control method Methods 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- 210000002381 plasma Anatomy 0.000 claims abstract description 79
- 239000000243 solution Substances 0.000 claims abstract description 43
- 210000004369 blood Anatomy 0.000 claims abstract description 38
- 239000008280 blood Substances 0.000 claims abstract description 38
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims abstract description 29
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims abstract description 29
- 102000008946 Fibrinogen Human genes 0.000 claims abstract description 29
- 108010049003 Fibrinogen Proteins 0.000 claims abstract description 29
- 239000003114 blood coagulation factor Substances 0.000 claims abstract description 29
- 229940012952 fibrinogen Drugs 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 21
- 238000010790 dilution Methods 0.000 claims abstract description 18
- 239000012895 dilution Substances 0.000 claims abstract description 18
- 239000012452 mother liquor Substances 0.000 claims abstract description 15
- 238000007865 diluting Methods 0.000 claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 4
- 230000033228 biological regulation Effects 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 claims description 70
- 238000012360 testing method Methods 0.000 claims description 32
- 241000282898 Sus scrofa Species 0.000 claims description 26
- 239000011259 mixed solution Substances 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 19
- 238000005070 sampling Methods 0.000 claims description 13
- 239000011159 matrix material Substances 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000001509 sodium citrate Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000003146 anticoagulant agent Substances 0.000 claims description 8
- 229940127219 anticoagulant drug Drugs 0.000 claims description 8
- 239000012043 crude product Substances 0.000 claims description 8
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000013049 sediment Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 210000001367 artery Anatomy 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 238000003307 slaughter Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 229960000182 blood factors Drugs 0.000 claims description 2
- 238000003113 dilution method Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 235000013601 eggs Nutrition 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 abstract description 3
- 230000023597 hemostasis Effects 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract description 2
- 238000004088 simulation Methods 0.000 abstract description 2
- 230000023555 blood coagulation Effects 0.000 description 13
- 208000007536 Thrombosis Diseases 0.000 description 11
- 239000000523 sample Substances 0.000 description 10
- 102000009123 Fibrin Human genes 0.000 description 8
- 108010073385 Fibrin Proteins 0.000 description 8
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 8
- 229950003499 fibrin Drugs 0.000 description 8
- 235000011083 sodium citrates Nutrition 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 230000008676 import Effects 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001411320 Eriogonum inflatum Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000013102 re-test Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000037486 Postoperative Hemorrhage Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 102000005525 fibrillarin Human genes 0.000 description 1
- 108020002231 fibrillarin Proteins 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000008747 shengyu Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical class [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
序号 | R(min) | K(min) | Angle(deg) | MA(mm) |
1 | 4.2 | 1.2 | 75.1 | 70.7 |
2 | 4.6 | 1.5 | 76.8 | 69.5 |
序号 | R(min) | K(min) | Angle(deg) | MA(mm) |
1 | 2.5 | 2.6 | 63.8 | 41.5 |
2 | 2.4 | 2.5 | 62.1 | 42.1 |
序号 | R(min) | K(min) | Angle(deg) | MA(mm) |
1 | 2.2 | 1.2 | 80.3 | 55.6 |
2 | 2.4 | 1.0 | 81.2 | 54.1 |
序号 | R(min) | K(min) | Angle(deg) | MA(mm) |
1 | 0.8 | 1.0 | 83.5 | 57.3 |
2 | 1.0 | 0.9 | 84.2 | 56.8 |
R(min) | K(min) | Angle(deg) | MA(mm) | |
0小时 | 0.9 | 1.0 | 84.5 | 57.2 |
3小时 | 0.9 | 1.0 | 84.6 | 56.4 |
6小时 | 1.0 | 1.0 | 83.5 | 56.0 |
9小时 | 1.3 | 1.4 | 82.6 | 53.2 |
12小时 | 1.5 | 1.6 | 79.2 | 51.8 |
24小时 | 2.0 | 2.4 | 75.4 | 49.5 |
R(min) | K(min) | Angle(deg) | MA(mm) | |
0个月 | 0.9 | 0.9 | 83.8 | 57.6 |
3个月 | 0.8 | 1.0 | 82.6 | 57.4 |
6个月 | 0.9 | 1.0 | 83.0 | 56.8 |
9个月 | 1.0 | 0.9 | 84.0 | 54.8 |
12个月 | 0.9 | 1.0 | 83.5 | 55.8 |
15个月 | 1.0 | 1.0 | 82.9 | 56.8 |
18个月 | 1.0 | 1.0 | 83.6 | 54.6 |
21个月 | 1.0 | 0.9 | 83.0 | 53.4 |
24个月 | 1.0 | 1.0 | 82.1 | 52.6 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511026362.9A CN105652022B (zh) | 2015-12-31 | 2015-12-31 | 血栓弹力图仪质控品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511026362.9A CN105652022B (zh) | 2015-12-31 | 2015-12-31 | 血栓弹力图仪质控品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105652022A CN105652022A (zh) | 2016-06-08 |
CN105652022B true CN105652022B (zh) | 2017-10-10 |
Family
ID=56490462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511026362.9A Active CN105652022B (zh) | 2015-12-31 | 2015-12-31 | 血栓弹力图仪质控品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105652022B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107588998B (zh) * | 2017-01-12 | 2021-10-22 | 上海原科实业发展有限公司 | 血栓弹力图仪质控品及其制备方法 |
CN107102125B (zh) * | 2017-04-17 | 2019-07-09 | 中国科学院苏州生物医学工程技术研究所 | 血栓弹力图仪的校准方法 |
CN109839058A (zh) * | 2017-11-24 | 2019-06-04 | 赫安仕科技(苏州)有限公司 | 一种用于血栓弹力图仪的非接触式电感式测量角度装置及其测量方法 |
CN108169467B (zh) * | 2017-11-27 | 2019-09-20 | 中国科学院苏州生物医学工程技术研究所 | 一种血栓弹力图仪质控品及其制备方法和应用 |
CN109541242B (zh) * | 2018-11-29 | 2022-06-14 | 武汉中科和信生物技术有限公司 | 一种高岭土试剂质控品及其制备方法和应用 |
CN109596845A (zh) * | 2018-12-27 | 2019-04-09 | 贵州金玖生物技术有限公司 | 一种血栓弹力图仪质控品及其制备方法 |
CN111983207A (zh) * | 2019-05-23 | 2020-11-24 | 宁德市医院 | 一种血栓弹力图仪全血质控品及配制方法 |
CN112378717B (zh) * | 2020-10-10 | 2023-03-24 | 中国科学院苏州生物医学工程技术研究所 | 两水平活化凝血检测试剂质控品及其制备方法 |
CN112697557B (zh) * | 2020-12-30 | 2024-08-16 | 郑州普湾医疗技术有限公司 | 一种2水平血栓弹力图质控品、制备方法及其应用 |
CN112841171A (zh) * | 2021-01-12 | 2021-05-28 | 广州鸿泉生物科技有限公司 | 用于血栓试验中的抗凝猪血、猪血浆的制备方法及应用 |
CN113325185B (zh) * | 2021-07-09 | 2024-04-19 | 重庆鼎润医疗器械有限责任公司 | 多水平质控品及其制备方法和在血栓弹力图检测上的应用 |
CN115343379A (zh) * | 2022-04-20 | 2022-11-15 | 杭州谱聚医疗科技有限公司 | 空白血基质和标准品的制备方法、维生素的检测方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009075891A2 (en) * | 2007-12-12 | 2009-06-18 | Kmg2 Sensors Corporation (Kmg2) | Magnetoelastic sensor element having a liquid-solid interface with a roughened nano/microstructure |
EP2741086A1 (en) * | 2012-12-06 | 2014-06-11 | Ludwig Boltzmann Gesellschaft | Method for measuring coagulation of blood samples using viscoelastic tests (VET) |
CN105092864A (zh) * | 2014-05-15 | 2015-11-25 | 北京乐普医疗科技有限责任公司 | 一种3水平血栓弹力图质控品及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001007921A2 (en) * | 1999-07-23 | 2001-02-01 | Medical Analysis Systems, Inc. | Stabilized coagulation control reagent |
DE102005005824A1 (de) * | 2005-02-08 | 2006-08-17 | Zlb Behring Gmbh | Methode zur Differenzierung von Faktor XIII-gegenüber Fibrinogen-Mangelzuständen unter Einsatz thrombelastographischer Techniken |
DE102005028018A1 (de) * | 2005-06-16 | 2006-12-21 | Dade Behring Marburg Gmbh | Verfahren zur Standardisierung von Gerinnungstesten |
EP2508892A1 (de) * | 2011-04-04 | 2012-10-10 | Siemens Healthcare Diagnostics Products GmbH | Kontrollen und Kit für Thrombozytenaktivitätsteste |
CN103163307B (zh) * | 2013-03-20 | 2015-06-03 | 上海太阳生物技术有限公司 | 凝血质控品及其制备方法 |
JP6526717B2 (ja) * | 2014-05-05 | 2019-06-05 | ヘモネティクス・コーポレーションHaemonetics Corporation | 線維素溶解及び線溶亢進を検出するための方法及び試薬 |
-
2015
- 2015-12-31 CN CN201511026362.9A patent/CN105652022B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009075891A2 (en) * | 2007-12-12 | 2009-06-18 | Kmg2 Sensors Corporation (Kmg2) | Magnetoelastic sensor element having a liquid-solid interface with a roughened nano/microstructure |
EP2741086A1 (en) * | 2012-12-06 | 2014-06-11 | Ludwig Boltzmann Gesellschaft | Method for measuring coagulation of blood samples using viscoelastic tests (VET) |
CN105092864A (zh) * | 2014-05-15 | 2015-11-25 | 北京乐普医疗科技有限责任公司 | 一种3水平血栓弹力图质控品及其应用 |
Non-Patent Citations (3)
Title |
---|
Correlation of conventional thrombelastography and rapid;Tim H.Lee et al.;《The American Journal of Surgery》;20130531;第205卷(第5期);521-527 * |
血栓弹力图室内质控方案的探讨;高旭蓉等;《北京医学》;20150430;第37卷(第4期);377-380 * |
血栓弹力图研究进展概况;蔡毅等;《中华老年心血管病杂志》;20141130;第16卷(第11期);1217-1218 * |
Also Published As
Publication number | Publication date |
---|---|
CN105652022A (zh) | 2016-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105652022B (zh) | 血栓弹力图仪质控品及其制备方法 | |
CN108169467B (zh) | 一种血栓弹力图仪质控品及其制备方法和应用 | |
CN103163307B (zh) | 凝血质控品及其制备方法 | |
CN109541242A (zh) | 一种高岭土试剂质控品及其制备方法和应用 | |
CN105424945B (zh) | 一种凝血激活检测试剂及其制备方法与用途 | |
CN103197083B (zh) | D-二聚体质控品及其制备方法 | |
CN101221189A (zh) | 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒 | |
CN107266563A (zh) | 一种血红蛋白质控品的制备方法 | |
CN104630325B (zh) | 一种液体型纤维蛋白原检测试剂及其制备方法 | |
CN107677839A (zh) | 一种d‑二聚体和fdp复合质控品的制备方法 | |
CN107588998B (zh) | 血栓弹力图仪质控品及其制备方法 | |
CN103764028B (zh) | 凝固控制剂和包含凝固控制剂的装置 | |
CN109497045A (zh) | 一种保存液及其制备方法与应用 | |
CN110346582A (zh) | 一种凝血复合质控品及其制备方法 | |
CN107271234A (zh) | 尿液有形成分分析仪用质控物/控制物质及其制备方法 | |
CN105368916B (zh) | 一种凝血酶原时间测定试剂盒及其制备方法 | |
CN107576789A (zh) | 一种冻干nk细胞表面抗原质控品及其制备方法 | |
Nepstad et al. | Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation | |
CN112697557B (zh) | 一种2水平血栓弹力图质控品、制备方法及其应用 | |
CN109709292A (zh) | 一种肝素检测试剂盒及其应用 | |
CN104914256A (zh) | 用作体外试验中异常凝血对照血浆的组合物 | |
Baumgarten et al. | Changes of platelet function and blood coagulation during short-term storage of CPDA-1-stabilised ovine blood | |
RU2401103C1 (ru) | Способ коррекции начинающейся вазопатии при анемии у новорожденных телят и поросят | |
CN111983207A (zh) | 一种血栓弹力图仪全血质控品及配制方法 | |
RU2402901C1 (ru) | Способ коррекции ослабления функций стенки сосудов при анемии у новорожденных телят и поросят |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application | ||
CI01 | Publication of corrected invention patent application |
Correction item: Inventor Correct: Zhao Lei|Yan Jing|Yang Bingfei False: Zhao Lei|Yan Jing|Yang Bingfei Number: 23 Volume: 32 |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Thromboelastography quality control material and preparation method thereof Effective date of registration: 20191017 Granted publication date: 20171010 Pledgee: Bank of Hangzhou Limited by Share Ltd. science and Technology Branch Pledgor: ZHEJIANG SHENGYU MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2019330000122 |